Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
10-25+ pounds over a 12-week program with proper adherence
(See GLP-1 research .) GLP-1 research Glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant weight loss benefits in patients with obesity, making them a valuable tool in weight management
Many side effects are dose-related and will resolve when it is adjusted or at the end of therapy
5 Non-alcoholic fatty liver disease (NAFLD) ranges from simple liver steatosis at the initial stage to non-alcoholic steatohepatitis (NASH), which, if not controlled, can further develop into cirrhosis and hepatocellular cancer, seriously threatening human health
For Wegovy pill based on baseline body weight of 235 lb., and for placebo based on baseline body weight of 231 lb
Independently verified
US$ 27.10
US$ 28.09
US$ 25.88
US$ 25.45
US$ 25.47
